Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorTechnische Universität Dresden

About this trial

The primary objective of this clinical trial is to evaluate whether primary total pancreatectomy with simultaneous islet autotransplantation compared with pancreatic head resection (alone) can reduce perioperative morbidity and time to initiation of adjuvant therapy in patients with a high-risk constellation for pancreatic fistulas.

Eligibility criteria

Qualifiers

suspected or confirmed periampullary carcinoma (tumor) and indication for PPPD (pylorus-preserving pancreaticoduodenectomy) or Whipple surgery

high-risk profile for the development of a postoperative pancreatic fistula (POPF) after pancreatic head resection: soft pancreas and Pancreatic duct diameter < 3 mm (preoperative and intraoperative confirmation)

written informed consent of the participant after successful Informed consent

Disqualifiers

patients on whom another procedure is to be performed simultaneously in addition to PPPD or Whipple surgery

confirmed other primary tumor

previous transplantation of an organ or tissue

known infection with HIV (HIV antibodies)

Trial design

Treatments tested in this trial

  • Intraportal transplantation of isolated autologous pancreatic islets after total pancreatectomy
  • Pancreaticoduodenectomy (classic Whipple or pylorus-preserving)

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Technische Universität Dresden

Lead sponsor

German Cancer Research Center

Collaborator